 Mamuka Kvaratskhelia
Concepts (413)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Integrase | 36 | 2024 | 70 | 10.250 |
Why?
| | HIV-1 | 47 | 2025 | 864 | 9.800 |
Why?
| | HIV Integrase Inhibitors | 25 | 2024 | 70 | 7.930 |
Why?
| | Virus Integration | 18 | 2025 | 71 | 3.870 |
Why?
| | Drug Resistance, Viral | 6 | 2025 | 116 | 2.750 |
Why?
| | Virus Replication | 14 | 2025 | 483 | 2.730 |
Why?
| | Anti-HIV Agents | 7 | 2025 | 778 | 2.630 |
Why?
| | Protein Multimerization | 9 | 2020 | 192 | 2.500 |
Why?
| | Intercellular Signaling Peptides and Proteins | 11 | 2021 | 382 | 2.420 |
Why?
| | Capsid | 8 | 2025 | 93 | 1.850 |
Why?
| | Capsid Proteins | 7 | 2025 | 94 | 1.780 |
Why?
| | DNA, Viral | 11 | 2022 | 364 | 1.630 |
Why?
| | Protein Binding | 44 | 2025 | 2224 | 1.610 |
Why?
| | RNA, Viral | 14 | 2022 | 656 | 1.580 |
Why?
| | Virion | 7 | 2022 | 93 | 1.510 |
Why?
| | HIV Infections | 19 | 2025 | 2836 | 1.470 |
Why?
| | HEK293 Cells | 23 | 2025 | 730 | 1.300 |
Why?
| | Integrases | 6 | 2017 | 120 | 1.150 |
Why?
| | Virus Assembly | 6 | 2025 | 78 | 1.140 |
Why?
| | Acetamides | 2 | 2025 | 36 | 1.130 |
Why?
| | Indazoles | 2 | 2025 | 69 | 1.120 |
Why?
| | Leukemia Virus, Murine | 4 | 2016 | 18 | 1.090 |
Why?
| | Allosteric Regulation | 13 | 2023 | 97 | 1.010 |
Why?
| | Gene Products, gag | 4 | 2018 | 36 | 1.010 |
Why?
| | Retroviridae | 3 | 2025 | 97 | 1.000 |
Why?
| | Models, Molecular | 24 | 2025 | 1570 | 0.970 |
Why?
| | Mass Spectrometry | 15 | 2017 | 739 | 0.960 |
Why?
| | Antiviral Agents | 6 | 2024 | 744 | 0.940 |
Why?
| | Endodeoxyribonucleases | 8 | 2001 | 72 | 0.920 |
Why?
| | Human T-lymphotropic virus 1 | 7 | 2023 | 28 | 0.910 |
Why?
| | Pyridines | 2 | 2019 | 506 | 0.900 |
Why?
| | Nucleosomes | 3 | 2022 | 155 | 0.890 |
Why?
| | Acetates | 3 | 2014 | 99 | 0.890 |
Why?
| | Pyrazines | 1 | 2025 | 90 | 0.880 |
Why?
| | HIV Reverse Transcriptase | 7 | 2019 | 31 | 0.860 |
Why?
| | Nuclear Pore Complex Proteins | 5 | 2025 | 38 | 0.850 |
Why?
| | Mutation, Missense | 3 | 2014 | 341 | 0.840 |
Why?
| | Genome, Viral | 4 | 2021 | 144 | 0.810 |
Why?
| | Prions | 1 | 2022 | 46 | 0.770 |
Why?
| | Nuclear Proteins | 5 | 2016 | 712 | 0.750 |
Why?
| | HIV Seropositivity | 1 | 2022 | 125 | 0.740 |
Why?
| | Transcription Factors | 7 | 2017 | 1719 | 0.740 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 8 | 2014 | 144 | 0.730 |
Why?
| | Crystallography, X-Ray | 7 | 2025 | 476 | 0.680 |
Why?
| | Protein Conformation | 14 | 2025 | 934 | 0.670 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 84 | 0.660 |
Why?
| | Protein Structure, Tertiary | 14 | 2016 | 861 | 0.570 |
Why?
| | Gene Products, pol | 1 | 2017 | 6 | 0.560 |
Why?
| | Sulfolobus | 7 | 2001 | 11 | 0.560 |
Why?
| | Quinolines | 3 | 2014 | 178 | 0.540 |
Why?
| | DNA | 13 | 2014 | 1459 | 0.530 |
Why?
| | Humans | 66 | 2025 | 137585 | 0.520 |
Why?
| | Protein Interaction Domains and Motifs | 6 | 2019 | 150 | 0.510 |
Why?
| | Archaeal Proteins | 3 | 2001 | 50 | 0.510 |
Why?
| | Binding Sites | 15 | 2021 | 1303 | 0.500 |
Why?
| | Amino Acid Sequence | 19 | 2019 | 2139 | 0.490 |
Why?
| | Recombinant Proteins | 6 | 2013 | 1353 | 0.480 |
Why?
| | Recombination, Genetic | 6 | 2001 | 204 | 0.470 |
Why?
| | Protein Footprinting | 6 | 2011 | 11 | 0.460 |
Why?
| | Molecular Sequence Data | 19 | 2015 | 2900 | 0.450 |
Why?
| | Moloney murine leukemia virus | 1 | 2014 | 13 | 0.450 |
Why?
| | Myxovirus Resistance Proteins | 3 | 2025 | 13 | 0.440 |
Why?
| | Transcription Initiation Site | 2 | 2014 | 43 | 0.440 |
Why?
| | HeLa Cells | 5 | 2020 | 636 | 0.440 |
Why?
| | Viral Proteins | 5 | 2016 | 342 | 0.420 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2015 | 230 | 0.410 |
Why?
| | Cell Line | 12 | 2025 | 2847 | 0.410 |
Why?
| | Cell Cycle Proteins | 6 | 2017 | 617 | 0.410 |
Why?
| | Nucleic Acid Conformation | 9 | 2021 | 728 | 0.410 |
Why?
| | Protein Domains | 5 | 2025 | 289 | 0.400 |
Why?
| | beta Karyopherins | 1 | 2012 | 8 | 0.390 |
Why?
| | Host-Pathogen Interactions | 5 | 2021 | 364 | 0.390 |
Why?
| | Integrase Inhibitors | 1 | 2012 | 1 | 0.390 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2022 | 29 | 0.370 |
Why?
| | Avian Leukosis Virus | 2 | 2017 | 6 | 0.360 |
Why?
| | Indoles | 1 | 2014 | 412 | 0.350 |
Why?
| | RNA, Transfer | 2 | 2016 | 138 | 0.350 |
Why?
| | Mutation | 8 | 2025 | 3958 | 0.340 |
Why?
| | Archaea | 2 | 2001 | 82 | 0.340 |
Why?
| | Catalytic Domain | 8 | 2016 | 207 | 0.330 |
Why?
| | Nuclear Pore | 2 | 2021 | 19 | 0.330 |
Why?
| | Viral Nonstructural Proteins | 3 | 2016 | 65 | 0.310 |
Why?
| | Proteins | 4 | 2020 | 1009 | 0.310 |
Why?
| | Gene Products, tax | 3 | 2019 | 13 | 0.310 |
Why?
| | Peptides | 5 | 2018 | 985 | 0.310 |
Why?
| | DNA Footprinting | 1 | 2008 | 33 | 0.300 |
Why?
| | Structure-Activity Relationship | 5 | 2021 | 570 | 0.290 |
Why?
| | DNA-Binding Proteins | 9 | 2017 | 1502 | 0.290 |
Why?
| | Hepacivirus | 3 | 2016 | 261 | 0.280 |
Why?
| | RNA-Binding Proteins | 4 | 2018 | 422 | 0.280 |
Why?
| | Histones | 3 | 2022 | 636 | 0.270 |
Why?
| | Salicylates | 2 | 2016 | 28 | 0.270 |
Why?
| | Cytoplasm | 2 | 2021 | 274 | 0.260 |
Why?
| | Molecular Dynamics Simulation | 2 | 2020 | 213 | 0.260 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 6 | 2008 | 345 | 0.250 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 225 | 0.250 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2006 | 32 | 0.250 |
Why?
| | Holliday Junction Resolvases | 8 | 2001 | 8 | 0.250 |
Why?
| | Active Transport, Cell Nucleus | 3 | 2025 | 124 | 0.250 |
Why?
| | Lysine | 8 | 2022 | 294 | 0.240 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2017 | 41 | 0.240 |
Why?
| | Ribonuclease H, Human Immunodeficiency Virus | 2 | 2019 | 2 | 0.240 |
Why?
| | DNA Damage | 4 | 2021 | 420 | 0.240 |
Why?
| | Pyridoxal Phosphate | 1 | 2004 | 24 | 0.230 |
Why?
| | Avian Sarcoma Viruses | 1 | 2004 | 4 | 0.230 |
Why?
| | Cyclophilins | 1 | 2025 | 40 | 0.230 |
Why?
| | Aptamers, Nucleotide | 2 | 2018 | 83 | 0.220 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 66 | 0.220 |
Why?
| | Biotin | 2 | 2005 | 28 | 0.210 |
Why?
| | Protein Processing, Post-Translational | 3 | 2017 | 465 | 0.210 |
Why?
| | Viral Envelope Proteins | 1 | 2004 | 84 | 0.210 |
Why?
| | Y-Box-Binding Protein 1 | 1 | 2023 | 6 | 0.210 |
Why?
| | Magnesium | 3 | 2000 | 156 | 0.210 |
Why?
| | Receptors, Virus | 2 | 2019 | 83 | 0.200 |
Why?
| | Chromatography, Gel | 4 | 2009 | 127 | 0.200 |
Why?
| | RNA, Transfer, Lys | 1 | 2002 | 2 | 0.200 |
Why?
| | Molecular Chaperones | 1 | 2025 | 195 | 0.200 |
Why?
| | Succinimides | 1 | 2002 | 19 | 0.200 |
Why?
| | Cell Nucleus | 2 | 2021 | 620 | 0.200 |
Why?
| | Protein Structure, Quaternary | 4 | 2008 | 128 | 0.200 |
Why?
| | Mutagenesis, Site-Directed | 6 | 2009 | 375 | 0.200 |
Why?
| | Xeroderma Pigmentosum Group A Protein | 2 | 2014 | 5 | 0.200 |
Why?
| | Chromosomes, Human | 1 | 2022 | 44 | 0.200 |
Why?
| | Molecular Docking Simulation | 3 | 2019 | 114 | 0.200 |
Why?
| | Drugs, Investigational | 1 | 2022 | 33 | 0.190 |
Why?
| | Histone Code | 1 | 2022 | 34 | 0.190 |
Why?
| | Phenylalanine | 1 | 2022 | 68 | 0.190 |
Why?
| | Thiophenes | 2 | 2016 | 117 | 0.190 |
Why?
| | Carboxylic Acids | 2 | 2019 | 34 | 0.190 |
Why?
| | Oligonucleotides | 3 | 2018 | 148 | 0.190 |
Why?
| | Protein Subunits | 2 | 2015 | 239 | 0.190 |
Why?
| | Cryoelectron Microscopy | 2 | 2020 | 190 | 0.190 |
Why?
| | Proteolysis | 3 | 2017 | 177 | 0.190 |
Why?
| | Viral Core Proteins | 2 | 2012 | 18 | 0.190 |
Why?
| | Drug Discovery | 3 | 2019 | 142 | 0.190 |
Why?
| | Cyclophilin A | 2 | 2024 | 26 | 0.180 |
Why?
| | Glycine | 1 | 2022 | 176 | 0.180 |
Why?
| | HTLV-I Infections | 4 | 2019 | 24 | 0.180 |
Why?
| | Peroxidases | 2 | 1999 | 34 | 0.180 |
Why?
| | Reverse Transcription | 1 | 2021 | 20 | 0.180 |
Why?
| | Lentiviruses, Primate | 1 | 2021 | 13 | 0.180 |
Why?
| | RNA | 1 | 2008 | 921 | 0.180 |
Why?
| | Isoenzymes | 3 | 1999 | 304 | 0.170 |
Why?
| | Chromatin | 2 | 2022 | 519 | 0.170 |
Why?
| | Purines | 1 | 2002 | 176 | 0.170 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 30 | 0.170 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 50 | 0.170 |
Why?
| | Tea | 2 | 1997 | 21 | 0.170 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 840 | 0.170 |
Why?
| | Manganese | 2 | 1999 | 62 | 0.170 |
Why?
| | Cross-Linking Reagents | 2 | 2016 | 217 | 0.170 |
Why?
| | Base Sequence | 7 | 2016 | 2181 | 0.170 |
Why?
| | Necrosis | 1 | 2021 | 246 | 0.160 |
Why?
| | Retroviridae Proteins | 2 | 2017 | 11 | 0.160 |
Why?
| | Neuroblastoma | 1 | 2021 | 160 | 0.160 |
Why?
| | Reverse Transcriptase Inhibitors | 2 | 2011 | 84 | 0.160 |
Why?
| | Amino Acid Substitution | 2 | 2013 | 307 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2013 | 430 | 0.160 |
Why?
| | Stereoisomerism | 1 | 2019 | 96 | 0.150 |
Why?
| | Animals | 13 | 2025 | 36940 | 0.150 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2000 | 405 | 0.150 |
Why?
| | Protein Interaction Mapping | 3 | 2012 | 109 | 0.150 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 50 | 0.150 |
Why?
| | Amino Acids | 1 | 2022 | 497 | 0.150 |
Why?
| | Gene Products, vpr | 1 | 2018 | 2 | 0.150 |
Why?
| | Glycerol | 1 | 2018 | 94 | 0.150 |
Why?
| | Substrate Specificity | 4 | 2016 | 372 | 0.140 |
Why?
| | Protein Folding | 2 | 2016 | 280 | 0.140 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 87 | 0.130 |
Why?
| | High Mobility Group Proteins | 1 | 2017 | 44 | 0.130 |
Why?
| | Immunoblotting | 2 | 2016 | 308 | 0.130 |
Why?
| | Peroxidase | 1 | 1997 | 175 | 0.130 |
Why?
| | Transcriptional Elongation Factors | 1 | 2017 | 40 | 0.130 |
Why?
| | 5' Untranslated Regions | 2 | 2021 | 58 | 0.130 |
Why?
| | meta-Aminobenzoates | 1 | 2016 | 1 | 0.130 |
Why?
| | alpha-Defensins | 1 | 2016 | 10 | 0.130 |
Why?
| | Nucleocapsid | 1 | 2016 | 19 | 0.130 |
Why?
| | Adenosine | 1 | 2018 | 225 | 0.130 |
Why?
| | Mutant Proteins | 2 | 2014 | 103 | 0.130 |
Why?
| | Protein Structure, Secondary | 3 | 2008 | 374 | 0.130 |
Why?
| | Ribonuclease P | 1 | 2016 | 22 | 0.130 |
Why?
| | DNA Packaging | 1 | 2016 | 24 | 0.130 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 187 | 0.130 |
Why?
| | DNA, Single-Stranded | 3 | 2006 | 118 | 0.130 |
Why?
| | Dynamic Light Scattering | 1 | 2016 | 6 | 0.120 |
Why?
| | Nucleic Acids | 1 | 2016 | 71 | 0.120 |
Why?
| | Calcium | 2 | 2021 | 1199 | 0.120 |
Why?
| | Morphogenesis | 1 | 2016 | 166 | 0.120 |
Why?
| | Drug Design | 1 | 2016 | 167 | 0.120 |
Why?
| | NIH 3T3 Cells | 2 | 2013 | 144 | 0.120 |
Why?
| | Spectrometry, Fluorescence | 1 | 2016 | 168 | 0.120 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2005 | 385 | 0.120 |
Why?
| | Models, Chemical | 1 | 2016 | 263 | 0.110 |
Why?
| | Biotinylation | 2 | 2006 | 32 | 0.110 |
Why?
| | Histidine | 1 | 2014 | 64 | 0.110 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 361 | 0.110 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 118 | 0.110 |
Why?
| | Escherichia coli | 4 | 2007 | 815 | 0.110 |
Why?
| | Circular Dichroism | 2 | 2012 | 149 | 0.110 |
Why?
| | Peptide Mapping | 2 | 2007 | 64 | 0.100 |
Why?
| | Nucleoproteins | 2 | 2017 | 27 | 0.100 |
Why?
| | Hepatitis C | 1 | 2016 | 271 | 0.100 |
Why?
| | DNA Repair | 2 | 2009 | 231 | 0.100 |
Why?
| | Hydrolysis | 3 | 2007 | 177 | 0.100 |
Why?
| | Genetic Vectors | 1 | 2014 | 319 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 437 | 0.100 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 138 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2017 | 771 | 0.100 |
Why?
| | Azepines | 1 | 2013 | 90 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2014 | 539 | 0.100 |
Why?
| | Human T-lymphotropic virus 2 | 1 | 2012 | 1 | 0.100 |
Why?
| | HTLV-II Infections | 1 | 2012 | 2 | 0.100 |
Why?
| | Gene Expression Regulation, Viral | 3 | 2021 | 95 | 0.100 |
Why?
| | Thermodynamics | 3 | 2020 | 407 | 0.100 |
Why?
| | Scattering, Small Angle | 1 | 2012 | 26 | 0.100 |
Why?
| | Genetic Therapy | 1 | 2014 | 297 | 0.100 |
Why?
| | Indoleacetic Acids | 1 | 2012 | 10 | 0.100 |
Why?
| | Calorimetry | 3 | 2001 | 70 | 0.100 |
Why?
| | X-Ray Diffraction | 1 | 2012 | 104 | 0.100 |
Why?
| | Triazoles | 1 | 2013 | 147 | 0.090 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 3412 | 0.090 |
Why?
| | Potassium Permanganate | 2 | 2002 | 3 | 0.090 |
Why?
| | RNA Interference | 1 | 2013 | 469 | 0.090 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2011 | 14 | 0.090 |
Why?
| | Virology | 1 | 2010 | 24 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 596 | 0.080 |
Why?
| | DEAD-box RNA Helicases | 1 | 2010 | 76 | 0.080 |
Why?
| | Kinetics | 4 | 2009 | 1670 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 156 | 0.080 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 177 | 0.080 |
Why?
| | DNA Polymerase beta | 1 | 2009 | 5 | 0.080 |
Why?
| | Ribonuclease H | 3 | 2007 | 12 | 0.080 |
Why?
| | Cloning, Molecular | 2 | 2000 | 534 | 0.080 |
Why?
| | Furans | 1 | 2008 | 24 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 327 | 0.070 |
Why?
| | Urea | 1 | 2008 | 81 | 0.070 |
Why?
| | Conserved Sequence | 2 | 2017 | 239 | 0.070 |
Why?
| | Models, Biological | 3 | 2019 | 1783 | 0.070 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 433 | 0.070 |
Why?
| | Autoantigens | 1 | 2011 | 430 | 0.070 |
Why?
| | Nuclear Lamina | 1 | 2007 | 10 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 434 | 0.070 |
Why?
| | Macromolecular Substances | 2 | 2010 | 229 | 0.070 |
Why?
| | Multiprotein Complexes | 2 | 2011 | 163 | 0.060 |
Why?
| | RNA Splicing | 2 | 2015 | 269 | 0.060 |
Why?
| | Phytic Acid | 1 | 2006 | 42 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 396 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2023 | 622 | 0.060 |
Why?
| | Proteomics | 1 | 2013 | 1111 | 0.060 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2006 | 81 | 0.060 |
Why?
| | Ribonucleoproteins | 2 | 2020 | 105 | 0.060 |
Why?
| | Electron Spin Resonance Spectroscopy | 3 | 1999 | 95 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 1 | 2004 | 90 | 0.060 |
Why?
| | Phosphorylation | 3 | 2021 | 1759 | 0.060 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2004 | 8 | 0.060 |
Why?
| | Viral Fusion Proteins | 1 | 2004 | 17 | 0.060 |
Why?
| | Calreticulin | 1 | 2004 | 28 | 0.060 |
Why?
| | Avian Proteins | 1 | 2004 | 21 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2004 | 59 | 0.060 |
Why?
| | Carbohydrates | 1 | 2004 | 65 | 0.050 |
Why?
| | Glycosylation | 1 | 2004 | 151 | 0.050 |
Why?
| | Chickens | 1 | 2004 | 191 | 0.050 |
Why?
| | Dimerization | 4 | 2007 | 199 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 1091 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 17 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 125 | 0.050 |
Why?
| | GTP Phosphohydrolases | 1 | 2024 | 93 | 0.050 |
Why?
| | Oxidation-Reduction | 2 | 1997 | 1060 | 0.050 |
Why?
| | Genes, Viral | 1 | 2023 | 88 | 0.050 |
Why?
| | Oxazines | 1 | 2023 | 30 | 0.050 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 2003 | 34 | 0.050 |
Why?
| | Thymine | 1 | 2003 | 15 | 0.050 |
Why?
| | Acetylation | 1 | 2004 | 248 | 0.050 |
Why?
| | Retroelements | 1 | 2003 | 48 | 0.050 |
Why?
| | DNA, Fungal | 1 | 2003 | 80 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2002 | 106 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 976 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2022 | 79 | 0.050 |
Why?
| | Base Pair Mismatch | 1 | 2002 | 11 | 0.050 |
Why?
| | Static Electricity | 1 | 2022 | 118 | 0.050 |
Why?
| | Mice | 4 | 2013 | 17787 | 0.050 |
Why?
| | Pyrococcus | 1 | 2001 | 1 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2021 | 23 | 0.050 |
Why?
| | DNA Primers | 2 | 2000 | 515 | 0.050 |
Why?
| | Methylation | 1 | 2022 | 230 | 0.050 |
Why?
| | Fluorescence Polarization | 1 | 2001 | 37 | 0.050 |
Why?
| | Pyrococcus furiosus | 1 | 2001 | 3 | 0.040 |
Why?
| | Chromatography | 1 | 2001 | 24 | 0.040 |
Why?
| | Enzyme Stability | 2 | 1999 | 70 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2007 | 1164 | 0.040 |
Why?
| | Entropy | 1 | 2020 | 41 | 0.040 |
Why?
| | Genes, Archaeal | 1 | 2000 | 6 | 0.040 |
Why?
| | Candida albicans | 1 | 2000 | 54 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2004 | 706 | 0.040 |
Why?
| | Time Factors | 2 | 2001 | 6828 | 0.040 |
Why?
| | Dogs | 1 | 2021 | 413 | 0.040 |
Why?
| | DNA, Archaeal | 1 | 2000 | 17 | 0.040 |
Why?
| | Cations, Divalent | 1 | 1999 | 52 | 0.040 |
Why?
| | Phosphoglycerate Mutase | 1 | 1999 | 2 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2000 | 123 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2000 | 343 | 0.040 |
Why?
| | PDZ Domains | 1 | 2019 | 5 | 0.040 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 11 | 0.040 |
Why?
| | Sorting Nexins | 1 | 2019 | 12 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 955 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 2 | 2003 | 557 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2023 | 1250 | 0.040 |
Why?
| | G-Quadruplexes | 1 | 2018 | 19 | 0.040 |
Why?
| | Molecular Structure | 1 | 2019 | 489 | 0.040 |
Why?
| | Virus Internalization | 1 | 2018 | 49 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 622 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 327 | 0.040 |
Why?
| | Virulence | 1 | 2019 | 267 | 0.040 |
Why?
| | Ascorbate Peroxidases | 1 | 1997 | 2 | 0.040 |
Why?
| | Lipids | 1 | 2022 | 672 | 0.030 |
Why?
| | Salicylic Acid | 1 | 1997 | 10 | 0.030 |
Why?
| | Transfection | 2 | 2012 | 945 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1997 | 86 | 0.030 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 41 | 0.030 |
Why?
| | Cricetulus | 1 | 2017 | 109 | 0.030 |
Why?
| | Point Mutation | 2 | 2009 | 235 | 0.030 |
Why?
| | CHO Cells | 1 | 2017 | 161 | 0.030 |
Why?
| | Gene Products, rex | 1 | 2017 | 1 | 0.030 |
Why?
| | Molecular Weight | 1 | 1997 | 335 | 0.030 |
Why?
| | Chick Embryo | 1 | 2017 | 130 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 795 | 0.030 |
Why?
| | Hot Temperature | 1 | 2000 | 391 | 0.030 |
Why?
| | Simian foamy virus | 1 | 2016 | 3 | 0.030 |
Why?
| | Potyvirus | 1 | 2016 | 2 | 0.030 |
Why?
| | Plant Proteins | 1 | 1997 | 113 | 0.030 |
Why?
| | beta-Defensins | 1 | 2016 | 21 | 0.030 |
Why?
| | Chemical Precipitation | 1 | 2016 | 37 | 0.030 |
Why?
| | Acyltransferases | 1 | 2017 | 57 | 0.030 |
Why?
| | Cell Survival | 2 | 2011 | 1120 | 0.030 |
Why?
| | DNA Viruses | 1 | 2016 | 14 | 0.030 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2016 | 14 | 0.030 |
Why?
| | Protein Unfolding | 1 | 2016 | 31 | 0.030 |
Why?
| | Molecular Motor Proteins | 1 | 2016 | 45 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 175 | 0.030 |
Why?
| | Protein Stability | 1 | 2016 | 176 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2016 | 145 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 2486 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2018 | 611 | 0.030 |
Why?
| | DNA Helicases | 1 | 2016 | 145 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 5079 | 0.030 |
Why?
| | Arginine | 2 | 2007 | 271 | 0.030 |
Why?
| | Introns | 1 | 2015 | 258 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1317 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 810 | 0.030 |
Why?
| | CpG Islands | 1 | 2014 | 157 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2014 | 183 | 0.030 |
Why?
| | Genetic Variation | 1 | 2018 | 991 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 2012 | 25 | 0.020 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2012 | 5 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 2012 | 88 | 0.020 |
Why?
| | Rats | 1 | 2021 | 5647 | 0.020 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2012 | 27 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2015 | 532 | 0.020 |
Why?
| | Mice, Knockout | 2 | 2012 | 3015 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2553 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3196 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 340 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 691 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1916 | 0.020 |
Why?
| | G2 Phase | 1 | 2011 | 38 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 812 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2011 | 134 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2010 | 55 | 0.020 |
Why?
| | Hydroxyl Radical | 1 | 2011 | 92 | 0.020 |
Why?
| | Cell Division | 1 | 2011 | 794 | 0.020 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2008 | 17 | 0.020 |
Why?
| | Nucleotides | 1 | 2009 | 125 | 0.020 |
Why?
| | Fibroblasts | 1 | 2012 | 996 | 0.020 |
Why?
| | Lamin Type A | 1 | 2007 | 49 | 0.020 |
Why?
| | Tritium | 1 | 2006 | 76 | 0.020 |
Why?
| | Schiff Bases | 1 | 2006 | 7 | 0.020 |
Why?
| | 5-Hydroxytryptophan | 1 | 2006 | 21 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2006 | 15 | 0.020 |
Why?
| | Solutions | 1 | 2006 | 168 | 0.020 |
Why?
| | Palmitic Acids | 1 | 2005 | 10 | 0.020 |
Why?
| | Chymotrypsin | 1 | 2005 | 22 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2005 | 82 | 0.010 |
Why?
| | Replication Protein A | 1 | 2005 | 13 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2005 | 232 | 0.010 |
Why?
| | Plasmids | 1 | 2005 | 363 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 325 | 0.010 |
Why?
| | Tryptophan | 1 | 2005 | 183 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 402 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2005 | 366 | 0.010 |
Why?
| | RNA, Fungal | 1 | 2003 | 72 | 0.010 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2003 | 92 | 0.010 |
Why?
| | Fluorometry | 1 | 2001 | 17 | 0.010 |
Why?
| | Carbocyanines | 1 | 2001 | 33 | 0.010 |
Why?
| | Fluorescein | 1 | 2001 | 25 | 0.010 |
Why?
| | Cell Membrane | 1 | 2005 | 738 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 46 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2001 | 86 | 0.010 |
Why?
| | Stem Cells | 1 | 2005 | 594 | 0.010 |
Why?
| | Phanerochaete | 1 | 1999 | 1 | 0.010 |
Why?
| | Enzyme Reactivators | 1 | 1999 | 2 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 321 | 0.010 |
Why?
| | Spectrophotometry | 1 | 1999 | 61 | 0.010 |
Why?
| | Vanadates | 1 | 1999 | 14 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 2001 | 200 | 0.010 |
Why?
| | RNA Stability | 1 | 2000 | 117 | 0.010 |
Why?
| | Heme | 1 | 1999 | 78 | 0.010 |
Why?
| | Genes, Bacterial | 1 | 1999 | 164 | 0.010 |
Why?
| | Ligands | 1 | 2000 | 664 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1999 | 560 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2000 | 257 | 0.010 |
Why?
| | Temperature | 1 | 1999 | 679 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2001 | 879 | 0.010 |
Why?
| | Gene Expression | 1 | 1999 | 1502 | 0.010 |
Why?
|
|
Kvaratskhelia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|